Company has received final approval from USFDA for NDA submitted for Nilotinib Capsules 50 150 and 200 mg on 19th February 2025
20-फ़रवरी-2025
डाउनलोड पीडीएफ़
Cipla
Company has received final approval from USFDA for NDA submitted for Nilotinib Capsules 50 150 and 200 mg on 19th February 2025